1. MARKETS
  2. SECTOR : CHEMICALS & PETROCHEMICALS
  3. INDUSTRY : SPECIALTY CHEMICALS
  4. ALBEMARLE CORP.
Albemarle Corp.
XNYS: ALB
Slowing Down Stock
Download real time
95.48-2.70(-2.75%)
56.80% Fall from 52W High
2.2M
XNYS Volume

XNYS 16 Oct, 2026 5:30 PM (EDT)

Portfolio

Alert

My Notes

Albemarle quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Forecaster Analyst Estimates for Albemarle share price target, revenues, EPS, net income and more

Albemarle quarterly results: revenue, profit, and P&L – 13 quarter history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
Nested row level
Base Level
Export
  • POSITIVE

    Quarterly Revenue Albemarle Jun-2026 Quarterly Revenue is $1,743 Million which is growth of 31.1% YoY.

  • POSITIVE

    Quarterly Net Profit Albemarle Jun-2026 Quarterly Net Profit is $480 Million which is growth of 1996.2% YoY.

Albemarle Corp., Earnings Report - Quarterly Results, standalone, All financials are in USD Million and price data in USD
IndicatorGraphJun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24Sep '24Jun '24Mar '24Dec '23Sep '23Jun '23
Operating Rev.
1,743.31,428.71,4281,307.81,3301,076.91,231.71,354.71,430.41,360.72,356.22,310.62,370.2
Cost Of Rev.
1,153927.81,230.11,190.21,133.1920.61,093.51,458.71,4411,321.83,060.22,255.71,811.7
Gross Profit
590.3501197.9117.6196.9156.3138.2-104-10.638.9-704.154.9558.5
⌄
130146.6167.7151.3144.9137.6156176.7189.7218.4217195418.5
Operating Profit
460.3354.430.3-33.65218.7-17.8-280.7-200.3-179.5-921.1-140140
⌄
-30.9-33.1-57.8-51-49.9-49-44.7-47.8-35.2-38-34.4-29.3-25.6
Profit Before Tax
441.7254.2-285-239.2-9-1976.7-1,178.9-494.1-167.6-921-158.2168.4
Tax
9421.5157.3-30.634.1-410.6110.9-30.7-3.7118.9-8.643
⌄
438.3277.4-455.9-202.4-18.8-0.333.6-1,110.7-229.9-9.1-617.7302.5650
Diluted NI Avail to Com Stockholders Ann.
438.3277.4-455.9-202.4-18.8-0.333.6-1,110.7-229.9-9.1-617.7302.5650
Basic EPS
3.72.4-3.9-1.7-0.20.3-9.5-2-0.1-5.32.65.5
Diluted EPS After ExtraOrdinary
3.83-0.5-0.20.1-0.2-1.1-1.600.31.92.77.3
Number Of Shares End
118117.9117.7117.7117.7117.6117.6117.5117.5117.5117.4117.4117.3
Net Income Continuing Discontinued Operations
480319.1-414.2-160.722.941.475.3-1,069-188.22.5-617.7302.5650
Normalized Income
511.1401.5-62.1-22.213.1-21.4-127.9-1,051119.330.6217.6322.6863.6
Interest Income
-------------
Interest
30.933.157.85149.94944.747.835.23834.429.325.6
Net Interest Income
-30.9-33.1-57.8-51-49.9-49-44.7-47.8-35.2-38-34.4-29.3-25.6
EBIT
472.6287.3-227.2-188.24130121.4-1,131.1-458.9-129.6-853.4-128.8194
EBITDA
628.4445.1-63.5-23.7209.7191.8284.5-967.6-320.7-5.9-709.2-23.4287
Reconciled Cost Of Rev.
1,153927.81,230.11,190.21,133.1920.61,093.51,458.71,4411,321.83,060.22,255.71,811.7
Reconciled Depr.
155.8157.8163.7164.5168.7161.8163.1163.5138.3123.8144.1105.493.1
Profit From Continuing Operations
499.2329-401.8-147.935.249.385.1-1,060.6-176.616.7-603.3320.7676.4
Normalized EBITDA
635.7566184.1159.6214.2190.7262.3-139.4-28.4-5.9-813.6-23.4287
*All financials are in USD Million and price data in USD
Add metric to table
Search...

Albemarle competitor comparison and performance snapshot within industry

Albemarle annual results: revenue, profit, P&L, and margins as of Dec 2025 – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • NEGATIVE

    Annual Revenue Albemarle Dec-2025 Annual Revenue is $5,143 Million which is growth of -4.4% YoY.

  • POSITIVE

    Annual Net Profit Albemarle Dec-2025 Annual Net Profit is $-511 Million which is growth of 56.7% YoY.

Albemarle Corp., Earnings Report - Annual Results, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsTTMDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
⌄
-11.1%
10.4%
 5,142.75,377.59,617.27,320.13,3283,128.93,589.43,3753,0722,677.23,651.3
Cost Of Rev. Ann.
1.8%
16%
4,501.14,4745,3158,431.34,245.52,3302,134.12,331.72,157.71,9621,706.62,454.5
Gross Profit Ann.
-39.9%
-7.6%
1,406.8668.762.51,185.93,074.6998994.91,257.81,217.31,110970.61,196.9
Operating Exp. Ann.
0.3%
4.2%
595.5601.4704.81,005.2596.1495.5489591.7516.1522.2460.9615.1
Operating Profit Ann.
-69.9%
-33.2%
811.367.3-642.2180.72,478.5502.5505.8666.1701.1587.8509.6581.7
⌄
-
-
-172.8-207.7-165.6-116.1-123-61.5-73.1-57.7-52.4-115.4-65.2-132.7
Other Exp. Ann.
-
-
 -411.7-956182.178-307.4-59.2-45.5146-25.670.8-90.8
PBT Ann.
-
-
171.7-552.1-1,763.8246.72,433.4133.6373.5563794.7446.8515.3358.2
Tax Ann.
-26.2%
23.6%
242.3156.987.1430.3390.629.554.488.2144.8431.896.329.1
⌄
-
-
57.4-677.4-1,316.11,573.52,689.8123.7375.8533.2693.654.9643.7334.9
Diluted NI Avail to Com Stockholders Ann.
-
-
57.4-677.4-1,316.11,573.52,689.8123.7375.8533.2693.654.9643.7334.9
EPS Ann.
-
-
 -5.8-11.213.4231.13.556.40.55.73
Diluted EPS Ann.
-
-
 -5.8-11.213.422.81.13.556.30.55.73
Number Of Shares End
0.1%
2%
 117.7117.6117.4117.2117106.7106106110.5112.5112.2
Total Exp. Ann.
1.6%
14.1%
 5,075.56,019.89,436.54,841.62,825.52,623.12,923.32,673.82,484.22,167.63,069.6
Net Income Continuing Discontinued Operations Ann.
-
-
224.2-510.6-1,179.51,573.52,689.8123.7375.8533.2693.654.9643.7334.9
Normalized Income Ann.
-
-
828.3-92.6-275.32,6202,586.3470.4439.5642.5579515.9403.8500.9
Interest Income Ann.
-
-
 -----------
Interest Ann.
19.1%
23.2%
172.8207.7165.6116.112361.573.157.752.4115.465.2132.7
EBITDA Ann.
-52.1%
-14.3%
986.3314.3-1,009.6744.32,857.3449.1678.6834.11,047.8759.1806.6751
Reconciled Cost Of Rev. Ann.
1.8%
16%
4,501.14,4745,3158,431.34,245.52,3302,134.12,331.72,157.71,9621,706.62,454.5
Reconciled Depr. Ann.
29.9%
23.2%
641.8658.7588.6429.9300.8254232213.5200.7196.9226.2260.1
Profit From Continuing Operations Ann.
-
-
278.5-465.2-1,135.51,670.52,815.1199.9446.6604.4739.199.5680.8360.1
Normalized EBITDA Ann.
-36.1%
2%
1,545.5748.6124.8721.62,865.7153.1678.6834.1837.4759.1741.7890.3
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Total Rev. Ann.
1Y CHG
-4.4%
2Y CAGR
-26.9%
3Y CAGR
-11.1%
5Y CAGR
10.4%
7Y CAGR
6.2%
10Y CAGR
3.5%
Total Revenue Annual is falling faster than historical averages.
Operating Exp. Ann.
1Y CHG
-14.7%
2Y CAGR
-22.7%
3Y CAGR
0.3%
5Y CAGR
4.2%
7Y CAGR
2.2%
10Y CAGR
-0.2%
Operating Expenses Annual Cr is falling faster than historical averages.

Albemarle balance sheet as of Dec 2025: assets, liabilities, reserves, and borrowings – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • NEGATIVE

    Total Shareholders Fund Albemarle Dec-2025 Total Shareholders Fund is $7,298 Million which is growth of -5.5% YoY.

  • NEGATIVE

    Total Assets Albemarle Dec-2025 Total Assets is $16,374 Million which is growth of -1.4% YoY.

Albemarle Corp., Balance Sheet, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
⌄
1.9%
9.4%
16,374.216,609.718,270.715,456.510,974.110,4519,860.97,581.77,750.88,161.29,615
⌄
-3.2%
2%
6,592.86,4108,605.67,265.75,168.55,982.45,767.33,822.63,933.14,218.66,213.7
⌄
-2.9%
11.3%
7,298.37,726.49,412.27,982.65,625.34,268.23,932.33,585.33,674.63,795.13,254.4
Total Capitalization Ann.
4.2%
12.5%
12,652.813,079.712,953.211,197.67,629.67,035.66,795.24,983.25,089.95,916.86,429.1
Tangible Assets Ann.
8.8%
28.3%
7,819.58,148.17,520.66,077.13,718.72,253.61,998.81,6321,642.71,900.5-1,372.5
Working Capital Ann.
-3.3%
40.5%
2,210.11,875.81,656.52,445.9133.7404.3816.1815.31,276.62,166.5214.3
Invested Capital Ann.
-2.2%
6%
10,491.811,242.613,578.911,199.78,019.57,840.36,982.55,290.55,511.96,164.37,106.4
Tangible Book Value Ann.
-2.8%
19.9%
5,584.45,912.97,520.66,077.13,718.72,253.61,998.81,6321,642.71,900.5-1,372.5
Borrowings Ann.
-0.2%
-2.2%
3,296.73,615.74,280.43,316.42,521.23,688.83,188.11,705.21,837.42,369.33,852
Net Debt Ann.
-2.8%
-11%
1,575.52,323.93,276.91,7181,9552,825.32,437.21,149.9700.199.53,638.3
Share Issued Ann.
0.1%
2%
117.7117.6117.4117.2117106.8106105.6110.6112.5112.2
Number Of Shares End
0.1%
2%
117.7117.6117.4117.2117106.7106106110.5112.5112.2
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Total Assets Ann.
1Y CHG
-1.4%
2Y CAGR
-5.3%
3Y CAGR
1.9%
5Y CAGR
9.4%
7Y CAGR
11.6%
10Y CAGR
5.5%
Total Assets Annual is falling faster than historical averages.
Total Current Liabilities Ann.
1Y CHG
-8.6%
2Y CAGR
-28.9%
3Y CAGR
-13.1%
5Y CAGR
0%
7Y CAGR
6.2%
10Y CAGR
1.1%
Total Current Liabilities Annual Cr is falling faster than historical averages.
Total ShareHolders Funds Ann.
1Y CHG
-5.5%
2Y CAGR
-11.9%
3Y CAGR
-2.9%
5Y CAGR
11.3%
7Y CAGR
10.7%
10Y CAGR
8.4%
Total ShareHolders Funds Annual is falling faster than historical averages.

Albemarle ROE, ROCE, book value, and debt-to-equity ratio as of Dec 2025 – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • NEGATIVE

    Book Value Per Share Albemarle Book Value Per Share is $62 which is growth of -5.8% YoY.

  • NEUTRAL

    ROE Albemarle ROE is 0% which is growth of 0% YoY.

Albemarle Corp., Ratios, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
RoA Ann. %
-
-
--7.55%9.33%20.35%1.15%3.70%6.11%9.05%0.69%7.24%4.51%
ROE Ann. %
-
-
--15.36%18.09%39.53%2.50%9.16%14.19%19.11%1.47%18.26%14.52%
ROIC %
-
-
-0.6-4.310.81.31.72.7-3.79.52.7
OPM Ann. %
-66.2%
-39.5%
1.31%-11.94%1.88%33.86%15.10%16.17%18.56%20.77%19.13%19.04%15.93%
Inventory Turnover Ratio Ann.
-
-
-2.942.932.83.23.33.83.65.7
Asset Turnover Ann. %
-
-
-0.30.60.60.30.30.40.40.40.30.5
Working Capital Turnover Ann.
-8.5%
-21.5%
2.32.95.8324.97.74.44.12.41.217
Quick Ratio Ann.
-
-
-1.20.81.10.60.811.11.52.50.5
Current Ratio Ann.
-
-
-21.51.91.11.21.61.72.12.91.1
Interest Coverage Ratio Ann.
-
-
--9.73.120.83.26.110.816.24.98.93.7
LT Debt To Equity Ann.
-
-
-0.40.40.40.40.70.80.40.40.61
*All financials are in USD Million and price data in USD
Add metric to table
Search...

Albemarle cash flow: net, operating, investing, and financing flows as of Dec 2025 – 11 year history

Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
  • POSITIVE

    Cash From Operating Activity Albemarle Dec-2025 Cash From Operating Activity is $1,282 Million which is growth of 82.6% YoY.

  • NEGATIVE

    Net Cash Flow Albemarle Dec-2025 Net Cash Flow is $302 Million which is growth of -18.2% YoY.

Albemarle Corp., Cash Flow, standalone, All financials are in USD Million and price data in USD
IndicatorGraphCAGR 3 YrsCAGR 5 YrsDec '25Dec '24Dec '23Dec '22Dec '21Dec '20Dec '19Dec '18Dec '17Dec '16Dec '15
⌄
-12.4%
9.9%
1,282.3702.11,325.31,907.9344.3798.9719.4546.2304733.4360.7
⌄
-
-
-146-1,574.4-2,781.2-1,422.7-666.6-863.6-1,663.6-303.7-357.82,920.5-2,160.6
⌄
-
-
-834.21,241.7623.9611.950.2177.31,042.7-786.5-1,086.9-1,577.9-478.3
Cash Plus Cash Eqv. End Of Year Ann.
2.6%
16.7%
1,6181,192.2889.91,499.1439.3746.7613.1555.31,137.32,269.8213.7
Net Increase In Cash Plus Cash Eqv.s Ann.
-34.9%
21.8%
302.1369.4-831.91,097.1-272.1112.698.4-544.1-1,140.72,076-2,278.2
Cash Plus Cash Eqv. Begin Of Year Ann.
39.5%
14.2%
1,192.2889.91,499.1439.3746.7613.1555.31,137.32,269.8213.72,489.8
Income Tax Paid Supplemental Data Ann.
-15%
-
152.5262.9319.4248.1-------
Interest Paid Supplemental Data Ann.
25.2%
-
180.7150.710292.1-------
Capex Ann.
-
-
-589.8-1,685.8-2,149.3-1,261.7-953.7-850.5-851.8-700-317.7-196.7-227.7
Issuance Of Capital Stock Ann.
15.4%
-
2,236.81,453.9------
Issuance Of Debt Ann.
-69.3%
-37.4%
56.7112.4973.11,964.261589.81,597.8272,304.6
Repayment Of Debt Ann.
-
-
-511.4-744.3-28.9-1,096.7-1,173.8-250-301.6-113.6-639.5-1,416-2,626.2
Repurchase Of Capital Stock Ann.
-
-
--------500-250
Free Cash Flow Ann.
2.3%
-
692.5-983.7-824646.2-609.4-51.6-132.4-153.8-13.7536.8133
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Cash from Operating Act. Ann.
1Y CHG
82.6%
2Y CAGR
-1.6%
3Y CAGR
-12.4%
5Y CAGR
9.9%
7Y CAGR
13%
10Y CAGR
13.5%
Cash from Operating Activity Annual growth is higher than historical averages.
×